Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (Unaudited)

v3.24.3
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Total revenue $ 554 $ 1,557 $ 80,624 $ 137,388
Total cost of revenue 1,511 2,787 87,483 114,188
Gross profit (loss) (957) (1,230) (6,859) 23,200
Operating expenses:        
Research and development 1,684,063 1,690,538 4,613,703 4,337,254
General and administrative 893,969 854,025 2,695,041 2,682,951
Sales and marketing 320,642 293,963 996,992 870,189
Total operating expenses 2,898,674 2,838,526 8,305,736 7,890,394
Loss from operations (2,899,631) (2,839,756) (8,312,595) (7,867,194)
Interest income, net 209,283 99,275 490,556 318,922
Net loss $ (2,690,348) $ (2,740,481) $ (7,822,039) $ (7,548,272)
Net loss per share – basic and diluted (in dollars per share) $ (0.31) $ (0.44) $ (0.99) $ (1.22)
Weighted average number of shares outstanding – basic and diluted (in shares) 8,767,251 6,192,286 7,870,542 6,185,447
Development Revenue [Member]        
Total revenue $ 554 $ 1,557 $ 80,624 $ 100,000
Total cost of revenue 1,511 2,787 87,483 76,800
Grant [Member]        
Total revenue 0 0 0 37,388
Total cost of revenue $ 0 $ 0 $ 0 $ 37,338